Literature DB >> 26889774

Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development.

Yaofeng Cheng1, Ayman El-Kattan2, Yan Zhang3, Adrian S Ray4, Yurong Lai1.   

Abstract

Membrane transporters play a pivotal role in many organs to maintain their normal physiological functions and contribute significantly to drug absorption, distribution, and elimination. Knowledge gained from gene modified animal models or human genetic disorders has demonstrated that interruption of the transporter activity can lead to debilitating diseases or organ toxicities. Herein we describe transporter associated diseases and organ toxicities resulting from transporter gene deficiency or functional inhibition in the liver, kidney, gastrointestinal tract (GIT), and central nervous system (CNS). While proposing additional transporters as targets for drug-induced organ toxicity, strategies and future perspectives are discussed for transporter risk assessment in drug discovery and development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26889774     DOI: 10.1021/acs.chemrestox.5b00511

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  3 in total

Review 1.  Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape.

Authors:  Ali Kermanizadeh; Leagh G Powell; Vicki Stone; Peter Møller
Journal:  Int J Nanomedicine       Date:  2018-11-16

2.  Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.

Authors:  Siennah R Miller; Thomas R Lane; Kimberley M Zorn; Sean Ekins; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2021-05-12       Impact factor: 3.579

3.  Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.

Authors:  Gabriel Kigen; Geoffrey Edwards
Journal:  BMC Pharmacol Toxicol       Date:  2017-05-04       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.